| Description |
1 online resource (xi, 535 pages) : illustrations (color) |
| Series |
Updates in Hypertension and Cardiovascular Protection Series |
|
Updates in hypertension and cardiovascular protection.
|
| Contents |
Intro -- Introduction -- Contents -- Part I: Epidemiology of Hypertension and Hypertensive Heart Disease -- 1: Epidemiological Aspects: Prevalence and Risk of Heart Failure Related to Blood Pressure -- 1.1 The Prevalence and Incidence of Heart Failure (HF) -- 1.1.1 Heart Failure Definition and Classification -- 1.1.2 The Prevalence of Heart Failure -- 1.1.3 The Incidence of Heart Failure -- 1.1.4 Secular Trends in Heart Failure Epidemiology -- 1.1.5 Heart Failure Epidemiology in Middle- and Low-Income Countries -- 1.1.6 Mortality in Heart Failure |
|
1.2 The Epidemiology of Hypertension and Heart Failure -- 1.3 Conclusions -- References -- 2: An Update on the Prevalence of Heart Failure -- 2.1 Introduction -- 2.2 Definition of HF and Its Changes -- 2.2.1 Lifetime Risk -- 2.2.2 Prevalence -- 2.3 Heart Failure with a Reduced Versus a Preserved Ejection Fraction -- 2.4 Asymptomatic Left Ventricular Dysfunction (ALVD) -- 2.5 Future Directions -- References -- 3: Heart Failure in Severely Hypertensive Children -- 3.1 Introduction -- 3.2 Severe Hypertension and Heart Failure |
|
3.2.1 The Etiology of Severe Hypertension in Children and Adolescents -- 3.2.2 Clinical Presentation -- 3.2.3 Initial Investigations -- 3.2.4 Imaging Studies -- 3.2.5 Mechanisms -- 3.2.6 Treatment -- 3.3 Conclusions -- References -- Part II: Mechanisms of Heart Failure in Arterial Hypertension -- 4: Genetics of Hypertension and Heart Failure -- 4.1 Heritability of Hypertension and Heart Failure -- 4.2 Genetics of Hypertension and Heart Failure -- 4.2.1 Sodium and Intravascular Volume -- 4.2.1.1 Monogenic Hypertension Syndromes -- 4.2.1.2 Monogenic Hypotension Syndromes |
|
4.2.1.3 Polygenic Pathways -- 4.2.2 Vascular Mechanisms -- 4.2.3 The Autonomic Nervous System -- 4.2.4 Cardiomyopathies -- 4.2.5 Mendelian Randomization (MR) Studies -- 4.2.6 Future Directions -- References -- 5: High Heart Rate: A Predictor of Heart Failure in Healthy Subjects and a Risk Factor for Adverse Outcome in Patients with Heart Failure -- 5.1 Introduction -- 5.2 High Heart Rate As A Risk Factor for the Development of Heart Failure -- 5.2.1 High Heart Rate: A Risk Factor or a Marker of Disease? |
|
5.3 Association of High Heart Rate with Adverse Outcomes in Patients with Congestive Heart Failure -- 5.4 The Effect of Heart Rate Reduction in Patients with Heart Failure -- 5.4.1 The Effect of Beta-Blockers in Patients with a Preserved Left Ventricular Function -- 5.4.2 Ivabradine as a Heart Rate-Lowering Agent in Patients with HF -- 5.4.3 Use of Beta-Blockers in HF Patients with Atrial Fibrillation -- 5.5 Summary and Conclusions -- References -- 6: Blood Pressure Variability and Heart Failure: Pathophysiological and Clinical Aspects -- 6.1 Introduction -- 6.2 Relationship of BPV with Preclinical Cardiac Organ Damage |
| Summary |
The second edition of this well-received book will offer both new insights into the intimate mechanisms of transition from hypertension to heart failure and clinical practice advice on the prevention and treatment of heart failure in hypertensive population. Heart failure is the result of the hypertension's effects on the heart and it is a growing public health problem, as it affects 20-50% of the adult population in developed countries. In this context the international scientific community is continuously struggling to develop better strategies in screening, diagnosing and treating hypertension and its deleterious effects. Thus, this field is continuously changing, with new important information being added constantly. A part of the book dedicated to diagnostics, comprising a chapter on new perspectives on multimodality imaging and a special chapter on diastolic dysfunction. The arrhythmic complications of hypertensive heart disease are discussed in two chapters on atrial fibrillation and ventricular arrhythmias respectively. Readers will also find new chapters regarding hypertension and heart failure in special populations such as cancer patients, young patients, pregnancy and patients with a history of SARS-CoV2 infection. This book is a useful tool for clinicians but also to the research community interested in heart failure and consequences of hypertension on heart who want to be up-to-date with the new developments in the field |
| Notes |
Previous edition: 2019 |
|
Description based upon print version of record |
| Bibliography |
Includes bibliographical references and index |
| Subject |
Hypertension.
|
|
Heart failure.
|
|
Hypertension
|
|
Heart Failure
|
| Form |
Electronic book
|
| Author |
Dorobanţu, Maria, editor
|
|
Voicu, Victor A., editor
|
|
Grassi, Guido, 1954- editor.
|
|
Agabiti Rosei, Enrico, editor
|
|
Mancia, Giuseppe, editor
|
| ISBN |
9783031393150 |
|
3031393155 |
|
